Arenicin-1 (1-10)-Orn-Dap + Arenicin-1 (1-10)

General Information


DRACP ID  DRACP03840

Peptide Name   Arenicin-1 (1-10)-Orn-Dap + Arenicin-1 (1-10)

Sequence  RWCVYAYVRVXX,RWCVYAYVRV

Sequence Length  23

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C124H174N34O22S2

Absent amino acids  DEFGHIKLMNPQST

Common amino acids  V

Mass  316966

Pl  9.72

Basic residues  4

Acidic residues  0

Hydrophobic residues  10

Net charge  4

Boman Index  -2516

Hydrophobicity  38.26

Aliphatic Index  84.35

Half Life 
  /

Extinction Coefficient cystines  17085

Absorbance 280nm  776.59

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31234579

Title  Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13510

DRACP is developed by Dr.Zheng's team.